Home
Securities
Duncan Walsh Advisors
Brokerage
Additional Capabilities
Contact Us
- Duncan Advisor Resources Team
Login

Advisor Login

Existing Users Log InUsername or Email

Password

Remember Me

Forgot password? Click here to reset

New User? Click here to register

Check out the background of firms and investment professionals on FINRA's BrokerCheck.

Securities offered through Registered Representatives of Cambridge Investment Research, Inc., a Broker/Dealer, Member FINRA/SIPC. Investment advisory services offered through Investment Advisor Representatives of Cambridge Investment Research Advisors, Inc., a Registered Investment Advisor. Each company is independently responsible for the products and services they provide. Representatives of Cambridge Investment Research, Inc. do not provide tax or legal advice in their roles as registered representatives. Cambridge and Duncan Advisor Resources and its subsidiaries are separate entities.

Diversification and asset allocation strategies do not assure profit or protect against losses.

Brian Duncan, David Duncan, Nancy Conners, Edward Kavo, Alex Kline, Tim Kunkle, Anthony Marciano, Robert McCalmont, Larry Qvistgaard, Dean Giella, Frank Zoracki, Don Waite, Ron Kims, Paul Schifter, and Robb Stottlemyer are investment advisory representatives and registered representatives of Cambridge Investment Research, Inc. Adam Aretz and Joseph Lundie are registered representatives of Cambridge Investment Research, Inc. They are collectively registered in the following states:
AL, AK, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WI, and WV
for the sale of securities products and are collectively licensed in the following states:
AL, AK, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MS, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV, and WY to sell life insurance products.

“Cambridge Approval #226235.”

Privacy Policy | Terms of Use